Strategic AI partnerships and Maestro orchestration platform position UiPath for enterprise adoption. Read why PATH presents a compelling accumulation opportunity.

Philippe Botteri, a partner at Accel, launched the firm’s GlobalScape report on the main stage at WebSummit in Lisbon, ...

UiPath’s Chief People Officer, Agi Garaba, is re-thinking how to measure progress when automation becomes part of everyday ...

RBC Capital raised the firm’s price target on UiPath (PATH) to $14 from $12 and keeps a Sector Perform rating on the shares as part of a broader ...

UiPath is entering a new market for AI solutions through strategic partnerships that will take it to the next level of ...

If you want to brush up on your deep-tech knowledge, consider one of these five online, free deep-tech courses.

UiPath's consensus analyst price target has been modestly increased to $13.71 per share following the latest updates. This shift comes as experts weigh recent product announcements and revenue beats, ...

On Monday, UiPath PATH got a positive adjustment to its Relative Strength (RS) Rating, from 79 to 82. Please watch the video ...

Nadella’s commentary frames OpenAI as an “execution machine” and is encouraging. Coupled with about 800 million monthly active users and what the company claims is 1 million enterprise API customers, ...

Alphabet, UiPath, and GitLab are three tech stocks trading at attractive valuations with big opportunities ahead.

Nue, the revenue lifecycle platform transforming how companies manage quote-to-revenue operations, today announced Nue AI, the first context-aware AI designed to make modern revenue systems easier to ...

Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not be well-established and traditional approaches to evidence generation cannot ...